Vandria

Lausanne, Switzerland

Vandria creates mitophagy inducers that renew cells to address ageing and chronic disorders.

$10.1M raised

Aug 2024

Series A

Top Investors

30,000+ verified contacts

Emails, phones & LinkedIn profiles

How much funding has Vandria raised?

Vandria has raised $10.1M in total funding. The most recent round was Series A. The last funding was announced in August 2024.

Who are Vandria's investors?

Vandria's investors include +ND Capital, Innosuisse, Eurostars, Hevolution Foundation, Dolby Family Ventures.

Where is Vandria headquartered?

Vandria is headquartered in Lausanne, Switzerland.

What does Vandria do?

Vandria creates mitophagy inducers that renew cells to address ageing and chronic disorders.

What stage is Vandria at?

Vandria is at the Series A stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated August 21, 2024.

MLA

"Vandria — Funding & Investors." VCBacked, August 21, 2024, https://www.vcbacked.co/company/vandria. Accessed July 2, 2026.

APA

VCBacked. (2024). Vandria — Funding & Investors. Retrieved July 2, 2026, from https://www.vcbacked.co/company/vandria

Wikipedia (cite web)

{{cite web |title=Vandria — Funding & Investors |url=https://www.vcbacked.co/company/vandria |website=VCBacked |access-date=July 2, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated August 21, 2024.